Deletion of a Distal RANKL Gene Enhancer Delays Progression of Atherosclerotic Plaque Calcification in Hypercholesterolemic Mice

被引:3
|
作者
Shamsuzzaman, Sohel [1 ]
Onal, Melda [1 ]
St John, Hillary C. [1 ]
Pike, J. Wesley [1 ]
机构
[1] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA
关键词
RANKL; DISTAL ENHANCER; ATHEROSCLEROTIC PLAQUE; mu CT; PLAQUE CALCIFICATION; GENE REGULATION; PLAQUE RANKL; KAPPA-B LIGAND; SMOOTH-MUSCLE-CELLS; OSTEOCLAST DIFFERENTIATION FACTOR; TISSUE-SPECIFIC EXPRESSION; VITAMIN-D-RECEPTOR; VASCULAR CALCIFICATION; ARTERIAL CALCIFICATION; BONE LOSS; TNFSF11; GENE; T-CELLS;
D O I
10.1002/jcb.26074
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Receptor activator of NF-B ligand (RANKL) is a TNF-like cytokine which mediates diverse physiological functions including bone remodeling and immune regulation. RANKL has been identified in atherosclerotic lesions; however, its role in atherosclerotic plaque development remains elusive. An enhancer located 75kb upstream of the murine Rankl gene's transcription start site designated D5 is important for its calciotropic hormone- and cytokine-mediated expression. Here, we determined the impact of RANKL levels in atherosclerotic plaque development in the D5 enhancer-null (D5(-/-)) mice in an atherogenic Apoe(-/-) background fed a high-fat diet (HFD). Rankl mRNA transcripts were increased in aortic arches and thoracic aortae of Apoe(-/-) mice; however, this increase was blunted in Apoe(-/-);D5(-/-) mice. Similarly, higher Rankl transcripts were identified in splenic T lymphocytes in Apoe(-/-) mice, and their levels were reduced in Apoe(-/-);D5(-/-) mice. When analyzed by micro-computed tomography (mu CT), atherosclerotic plaque calcification was identified in six out of eight Apoe(-/-) mice, whereas only one out of eight Apoe(-/-);D5(-/-) mice developed plaque calcification after 12 weeks of HFD. However, following 18 weeks of HFD challenge, all of Apoe(-/-) and Apoe(-/-);D5(-/-) animals developed atherosclerotic plaque calcification. Likewise, atherosclerotic lesion sizes were site-specifically reduced in the aortic arch of Apoe(-/-);D5(-/-) mice at initial stage of atherosclerosis and this effect was diminished as atherosclerosis proceeded to a more advanced stage. Our data suggest that deletion of the RANKL D5 enhancer delays the progression of atherosclerotic plaque development and plaque calcification in hypercholesterolemic mice. This work provides important insight into RANKL's regulatory role in atherosclerosis. J. Cell. Biochem. 118: 4240-4253, 2017. (c) 2017 Wiley Periodicals, Inc.
引用
收藏
页码:4240 / 4253
页数:14
相关论文
共 50 条
  • [41] Fibronectin Extradomain A Modulates Atherosclerotic Lesion Progression in Hypercholesterolemic Mice Through Toll-Like Receptor 4
    Gandhi, Chintan
    Prakash, Prem
    Ahmad, Ajmal
    Chauhan, Anil
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34
  • [42] Sodium [18F]Fluoride PET Can Efficiently Monitor In Vivo Atherosclerotic Plaque Calcification Progression and Treatment
    Florea, Alexandru
    Sigl, Julius P.
    Morgenroth, Agnieszka
    Vogg, Andreas
    Sahnoun, Sabri
    Winz, Oliver H.
    Bucerius, Jan
    Schurgers, Leon J.
    Mottaghy, Felix M.
    CELLS, 2021, 10 (02) : 1 - 14
  • [43] Immune response and gene profiling at different stages of atherosclerotic plaque progression using mouse model
    Vrushali, V. D.
    Lakshmi, L. M.
    Vijay, V. K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 521 - 521
  • [44] Exercise training inhibits atherosclerosis progression and reduces VE-cadherin levels within atherosclerotic plaques in hypercholesterolemic mice
    Kadoglou, Nikolaos P. E.
    Stasinopoulou, Marianna
    Christodoulou, Eirini
    Valsami, Georgia
    Kostomitsopoulos, Nikolaos
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 623 : 39 - 43
  • [45] ADAMTS13 modulates atherosclerotic plaque progression in mice via a VWF-dependent mechanism
    Gandhi, C.
    Ahmad, A.
    Wilson, K. M.
    Chauhan, A. K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (02) : 255 - 260
  • [46] Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice
    Hara, Tomoya
    Fukuda, Daiju
    Tanaka, Kimie
    Higashikuni, Yasutomi
    Hirata, Yoichiro
    Nishimoto, Sachiko
    Yagi, Shusuke
    Yamada, Hirotsugu
    Soeki, Takeshi
    Wakatsuki, Tetsuzo
    Shimabukuro, Michio
    Sata, Masataka
    ATHEROSCLEROSIS, 2015, 242 (02) : 639 - 646
  • [47] Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice - Inhibitory effect on monocyte chemotaxis
    Pakala, R
    Stabile, E
    Dang, GJ
    Clavijo, L
    Waksman, R
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 46 (04) : 481 - 486
  • [48] LONG-TERM VITAMIN K ANTAGONIST TREATMENT INDUCES CALCIFICATION AND ATHEROSCLEROTIC PLAQUE PROGRESSION, PROMOTING A PRETHROMBOTIC STATE.
    Van Gorp, R.
    Jaminon, A.
    Baaten, C.
    Heemskerk, J.
    Reutelingsperger, C.
    Spronk, H.
    Schurgers, L.
    ATHEROSCLEROSIS, 2019, 287 : E74 - E75
  • [49] Inhibition of Coagulation factor Xa increases plaque stability and attenuates the onset and progression of atherosclerotic plaque in apolipoprotein e-deficient mice
    Posthuma, J. J.
    Posma, J. J. N.
    Van Oerle, R.
    Ten Cate, H. M. H.
    Spronk, H. M. H.
    EUROPEAN HEART JOURNAL, 2016, 37 : 789 - 790
  • [50] Inhibition of Coagulation factor Xa increases plaque stability and attenuates the onset and progression of atherosclerotic plaque in apolipoprotein e-deficient mice
    Posthuma, J. J.
    Posma, J. J. N.
    Van Oerle, R.
    Spronk, H. M. H.
    Ten Cate, H.
    CARDIOVASCULAR RESEARCH, 2016, 111 : S29 - S29